Actual Medicinal Product (AMP) Lisinopril 5mg tablets (Medreich Plc)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Medicines suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
- Notes
-
This compatibility recommendation is derived from Zestril 5mg tablets (Atnahs Pharma UK Ltd).
- Provenance
-
This compatibility recommendation is derived from Zestril 5mg tablets (Atnahs Pharma UK Ltd).
- Generic
- Lisinopril
- Formulation
- Lisinopril 5mg tablets
-
Lisinopril
-
Lisinopril 5mg tablets
-
Lisinopril 5mg tablets (Medreich Plc)
-
-
Lisinopril 2.5mg tablets